Skip to main content
. Author manuscript; available in PMC: 2015 Mar 1.
Published in final edited form as: Int J Radiat Oncol Biol Phys. 2014 Jan 7;88(3):565–571. doi: 10.1016/j.ijrobp.2013.11.232

Table 3.

Cumulative incidence of lymphedema at 24 months post-operative stratified by type of radiotherapy and axillary surgery.

Cumulative Incidence of Lymphedema (%, 95% Confidence Interval) (Number in subgroup)
Radiation Field(s) Entire cohort (n=1501) SLNB (n=928) ALND (n=395)
No radiation 3.0 (1.6–5.6) (n=402) 0.00 (0.00–0.00) (n=313) 18.27 (9.7–32.9) (n=60)
B/CW only 3.1 (2.0–4.7) (n=790) 2.82 (1.7–4.8) (n=569) 7.33 (3.1–16.8) (n=73)
B/CW + SC 21.9 (16.0–29.5) (n=194) 7.14 (1.0–40.9) (n=25) 23.93 (17.5–32.2) (n=169)
B/CW + SC + PAB 21.1 (13.8–31.5) (n=115) 4.76 (0.7–29.3) (n=21) 24.89 (16.2–37.1) (n=94)

Abbreviations: SLNB = Sentinel Lymph Node Biopsy, ALND = Axillary Lymph Node Dissection, B/CW= PBI or Whole breast/chest wall, SC= Supraclavicular, PAB= Posterior Axillary Boost